Ractigen Therapeutics IND application for RAG-1C receives FDA clearance

GlycoNex commences dosing in Phase I trial of GNX1021 in Japan

Datroway approved in EU for first-line metastatic triple-negative breast cancer

Karyopharm reports topline Phase 3 trial results in endometrial cancer

Kaigene and Taisho enter exclusive KG006 licensing agreement in Japan

Pfizer reports positive Phase 3 results for LITFULO in nonsegmental vitiligo

Octapharma to build USD1.5bn critical care manufacturing facility in Rock Hill, SC

Ractigen Therapeutics closes over USD31m financing for project advancement

10x Genomics and Lausanne University Hospital to collaborate on cancer care research

European Commission approves RINVOQ for severe alopecia areata

AbCellera and Vertex agree collaboration to develop multispecific T-cell engagers

Incyte's Opzelura approved in European Union for moderate atopic dermatitis

Synlogic and Caldera Therapeutics agree merger

RTW Biotech portfolio company Yarrow Bioscience completes merger

Hemogenyx partners with Lithuanian cancer centre on HG-CT-1 research and clinical programme